Skip to main content

Mckesson Medical-Surgical Inc. Corporate Office

5 ongoing recalls and 152 historical records

Based on the official records currently available to Public Health Trace, 5 recalls naming Mckesson Medical-Surgical Inc. Corporate Office are currently shown as ongoing. The other 152 records below are historical.

Public Health Trace has 157 recalls naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, republished from official FDA and USDA sources.

Recall records - 157 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
202290
20245
20255
Download CSV

FDA Recall TerminatedTerminated: February 13, 2024Historical recordClass II

Naphcon A eye drops, Naphazoline HCl 0.025% and Pheniramine Maleate 0.3%, Redness Reliever and Antihistamine Eye Drops, Sterile, 15 mL (0.5 FL OZ) bottle per box, Alcon, a Novartis company, NDC 0065-0085-15.

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
CGMP Deviations: products were stored outside the drug label specifications.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 13, 2024Historical recordClass II

Bisacodyl Suppositories, Fast Acting Stimulant Laxative, 100 suppositories per box, 10 mg each, Health Star, NDC 57896-443-01.

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
CGMP Deviations: products were stored outside the drug label specifications.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 13, 2024Historical recordClass II

Triple Antibiotic Ointment, Bacitracin zinc, Neomycin sulfate, Polymixin B sulfate, First Aid Antibiotic, Triple Antibiotic Ointment, 144 packets per box, Net wt. per packet 0.5 g, Honeywell Safety Products, NDC 0498-0750-36.

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
CGMP Deviations: products were stored outside the drug label specifications.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Paracentesis/Thoracentises Tray (10/cs) Rx CRFPED, Lidocaine Hydrochloride USP, 1%, 5mL, Rx only, MFG: Becton Dickinson

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Biopsy and Aspiration Tray Bone Marrow Illinois 11GX4 (10/cs) Rx CRFPED Lidocaine Hydrochloride USP, 1%, 5mL, Rx only, MFG: Becton Dickinson

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Ofloxacin Otic Solution 0.3%, 5 mL bottle, Rx only, MFG: Amneal/Akyma Pharmaceuticals, NDC 69238-1615-3

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.